Supplementary Table S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients

Supplementary Table S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients

<p>Supplementary Table 2. Complete table results for all patients (n=201) involved in baseline (C1D1) analysis.</p>

Kaydedildi:
Detaylı Bibliyografya
Yazar: Javier Pascual (15018176) (author)
Diğer Yazarlar: Miguel Gil-Gil (15052083) (author), Paula Proszek (17141889) (author), Christoph Zielinski (15054460) (author), Alistair Reay (17141892) (author), Manuel Ruiz-Borrego (15048425) (author), Rosalind Cutts (17141895) (author), Eva M. Ciruelos Gil (17141898) (author), Andrew Feber (15124144) (author), Montserrat Muñoz-Mateu (15054469) (author), Claire Swift (17141901) (author), Begoña Bermejo (15037896) (author), Jesus Herranz (15048443) (author), Mireia Margeli Vila (15054472) (author), Antonio Antón (15054475) (author), Zsuzsanna Kahan (17141904) (author), Tibor Csöszi (17141907) (author), Yuan Liu (15054484) (author), Daniel Fernandez-Garcia (17141910) (author), Isaac Garcia-Murillas (15018188) (author), Michael Hubank (15104113) (author), Nicholas C. Turner (17141913) (author), Miguel Martín (15011399) (author)
Baskı/Yayın Bilgisi: 2025
Konular:
Cancer
Cancer Detection and Diagnosis
Therapeutic Research and Development
Biomarkers
Circulating tumor cells/DNA/exosomes
Serum biomarkers
Breast Cancer
Translational Research
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
Diğer Bilgiler
Özet:<p>Supplementary Table 2. Complete table results for all patients (n=201) involved in baseline (C1D1) analysis.</p>

Benzer Materyaller